Related Experiment Video
Updated: Jun 30, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Cutaneous lymphoproliferative disorders: Back to the future.
1Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.
Recent classifications re-evaluate low-grade cutaneous lymphomas. Experts now recognize primary cutaneous CD4+ small/medium T-cell lymphoma (PCSM-TCL) and primary cutaneous marginal zone lymphoma (PCMZL) as lymphoproliferative disorders (LPDs) due to their indolent behavior and excellent prognosis.
Area of Science:
- Dermatology and Hematopathology
- Oncology and Lymphoid Neoplasms
- Immunohistochemistry and Molecular Diagnostics
Background:
- Immunohistochemistry and clonality analyses in the 1980s redefined cutaneous lymphomas.
- Criteria for T-cell and B-cell proliferations led to reclassification of benign conditions as lymphomas.
- Growing evidence questions the specificity of these markers for malignancy.
Purpose of the Study:
- To review the evolving terminology of cutaneous lymphomas.
- To discuss the rationale behind reclassifying certain lymphomas as lymphoproliferative disorders (LPDs).
- To analyze the clinical implications of this reclassification.
Main Methods:
- Review of historical diagnostic criteria and classifications.
- Analysis of recent studies on low-grade cutaneous lymphomas.
- Comparison of the WHO (2022) and International Consensus Classification (ICC, 2022) approaches.
Main Results:
- Low-grade cutaneous T-cell lymphoma (CTCL) and cutaneous B-cell lymphoma (CBCL) exhibit indolent behavior and excellent prognosis.
- Recent classifications (WHO 2022, ICC 2022) have downgraded PCSM-TCL and related conditions to LPDs.
- Terminology for primary cutaneous marginal zone lymphoma (PCMZL) differs between the WHO and ICC classifications.
Conclusions:
- The diagnostic landscape for cutaneous lymphoid proliferations is dynamic.
- Reclassification to LPD reflects a better understanding of the biology and clinical behavior of these conditions.
- Understanding these terminology shifts is crucial for accurate diagnosis and patient management.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

